Literature DB >> 2281826

Effects of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate on mouse osteoclasts.

M J Marshall1, A S Wilson, M W Davie.   

Abstract

A group of 5-day-old mice were injected intraperitoneally with (3-amino-1-hydroxypropylidine)-1,1-bisphosphonate (APD). Morphologic changes were observed in vitally stained osteoclasts on parietal bones 3 days later, and these were judged to be degenerative. At this time significantly increased numbers of nuclei per osteoclast and total numbers of osteoclast nuclei were observed. However, at 4 days after the injection of APD, the total numbers of osteoclasts were significantly reduced relative to controls. When parietal bones were maintained in culture, APD reduced osteoclast numbers and inhibited cell-mediated 45Ca2+ release. Exposure of bones to parathyroid hormone increased the number of osteoclasts counted 1 day later. This effect was not blocked by APD. Calcitonin prevented the reduction in osteoclast numbers due to APD in vitro. We conclude that APD has a direct effect on resorbing mouse osteoclasts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2281826     DOI: 10.1002/jbmr.5650050909

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  5 in total

1.  Osteoclast recruitment in mice is stimulated by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate.

Authors:  M J Marshall; I Holt; M W Davie
Journal:  Calcif Tissue Int       Date:  1993-01       Impact factor: 4.333

2.  Relationship between bisphosphonate concentration and osteoclast activity and viability.

Authors:  D J Rowe; L A Etre; M J Lovdahl; D J Pietrzyk
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Jul-Aug       Impact factor: 2.416

3.  The effect of 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (ADP) on the resorptive function of osteoclasts of known nuclear number.

Authors:  K Piper; A Boyde; S J Jones
Journal:  Calcif Tissue Int       Date:  1994-01       Impact factor: 4.333

Review 4.  Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

Authors:  Ann E Kearns; Sundeep Khosla; Paul J Kostenuik
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

5.  Influence of bisphosphonate treatment on medullary macrophages and osteoclasts: an experimental study.

Authors:  Natalia Daniela Escudero; Patricia Mónica Mandalunis
Journal:  Bone Marrow Res       Date:  2012-09-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.